Maryam Alkhatry & Barham Abu Dayyeh on "Improvements in hepatic steatosis, obesity, and insulin...

Maryam Alkhatry & Barham Abu Dayyeh on "Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure"
Primary obesity surgery endoluminal 2.0 (POSE 2.0) is an endoscopic procedure in which full-thickness plications are applied to reduce gastric lumen size. Adults with obesity and nonalcoholic fatty liver disease underwent POSE 2.0 with lifestyle modification (n = 20) or lifestyle modification alone (n = 22). At 12 months, POSE 2.0 significantly improved controlled attenuation parameter, and resulted in resolution of steatosis and increased percentage total body weight loss compared with lifestyle modification alone. Nonetheless, further studies are needed to elucidate the role of POSE 2.0 in subsets of patients with nonalcoholic steatohepatitis, and the efficacy and safety of the procedure in individuals with advanced fibrosis.
Find the article at: doi.org/10.1055/a-2117-6274
Maryam AlKhatry, Babusai Rapaka, Daniel B. Maselli et al. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure
Bibliography Endoscopy 2023; 55: 1028-1034 DOI 10.1055/a-2117-6274 ISSN 0013-726X © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG, Rüdigerstraße 14, 70469 Stuttgart, Germany